CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
36.95
+0.66 (1.82%)
At close: Jun 2, 2025, 4:00 PM
37.19
+0.24 (0.65%)
After-hours: Jun 2, 2025, 7:54 PM EDT

CRISPR Therapeutics AG Revenue

CRISPR Therapeutics AG had revenue of $865.00K in the quarter ending March 31, 2025, with 71.63% growth. This brings the company's revenue in the last twelve months to $37.68M, down -86.13% year-over-year. In the year 2024, CRISPR Therapeutics AG had annual revenue of $37.31M, down -89.95%.

Revenue (ttm)
$37.68M
Revenue Growth
-86.13%
P/S Ratio
83.75
Revenue / Employee
$95,865
Employees
393
Market Cap
3.19B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202437.31M-333.89M-89.95%
Dec 31, 2023371.21M370.01M30,885.48%
Dec 31, 20221.20M-913.77M-99.87%
Dec 31, 2021914.96M914.24M127,154.94%
Dec 31, 2020719.00K-288.87M-99.75%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.